Tribune News Service
New Delhi, November 24
A single dose of the Russian Sputnik V vaccine will cost less than $10 in international market while the two-dose regimen would cost $20 (around Rs 1,400), announced Krill Dmitriev, head of the Russian Direct Investment Fund, at a webinar on Tuesday.
At the launch, the vaccine would cost half or even less than other mRNA vaccines with similar efficacy, claimed Dmitriev. The RDIF and its partners have launched production of the lyophilised (dry) form of the vaccine, which is stored at a temperature of 2 to 8°C. Such a regime enables the distribution of the vaccine in international markets as well as expanding its use in hard-to-reach regions.
The current agreements between the RDIF and leading foreign pharmaceutical companies allow the Sputnik V vaccine to be produced abroad for 500 million people per year, starting from 2021. The first international deliveries of the Russian Sputnik V vaccine will be made to customers in January 2021.
The second interim analysis of clinical trial data showed a 91.4 per cent efficacy 28 days after the first dose; efficacy is over 95 per cent 42 days after the first dose, said its makers Gamaleya Institute.
- 2 to 8°C storage enables its distribution in far-flung areas
- 500 mn twin-dose annual production target beginning next year
- Jan 2021 the vaccine’s first international deliveries to begin
Free travel for women in govt buses | 48,989 vacancies to be...
145 legislators urge Lok Sabha Speaker to curtail proceeding...
Five sitting MLAs, other leaders join saffron party